	Intraplacental Choriocarcinoma Presenting With Postpartum Hemorrhage Requiring Uterine Artery Embolization: A Case Report. J Obstet Gynaecol Res Tsuge S, Yoshida K, Shirasaki M, Nakamura H, Niimi K, Kajiyama H. PMID: 42595378 [PubMed - indexed for MEDLINE]
	Dosimetric parameters of the axillary-lateral thoracic junction in predicting risk of breast cancer-related lymphedema. Radiother Oncol Hong SW, Kim EK, Shin HC, Beom J, Lim JY, Kim IA, Kim K. PMID: 42595256 [PubMed - as supplied by publisher]
	Modern Therapies: Nanotechnology Promises New Approaches for Rare Breast Cancer to Brain Metastases. SLAS Discov Muteeb G, El-Sayed AY, AboHoussien MS, Abuelnile RH, Shaaban AH, Jaafari JIA, Kumari S, Farhan M, Aatif M, Khafaga DSR. PMID: 42595178 [PubMed - as supplied by publisher]
	Aryl Hydrocarbon Receptor Activation by Imidacloprid as a Promoter of HER2(+) Breast Cancer Progression: In silico, in vitro and in vivo studies. Environ Res Buján S, Miret N, Torres D, Pontillo C, Chiappini F, Nicola Candia A, Agustina L, Sofia MM, Bressan M, Scicolone G, Candolfi M, Randi A. PMID: 42595034 [PubMed - as supplied by publisher]
	Senescence-Associated Mitochondrial Dysfunction as a Therapeutic Target in Ovarian Cancer: Challenges and Opportunities. Eur J Pharmacol Khalili HS, Abadi B, Rezaei N. PMID: 42594984 [PubMed - as supplied by publisher]
	Drug resistance in breast cancer brain metastasis: mechanisms and therapeutic strategies. Biochim Biophys Acta Rev Cancer Sarker P, Rao SS. PMID: 42594975 [PubMed - as supplied by publisher]
	Unraveling the association between triclosan and breast cancer: A multidimensional research strategy integrating machine learning, mendelian randomization, and molecular dynamics simulations. Environ Int Wu D, Yuan J, Xu H, Yang C, Pan J, Li G, Dai W, Gan J, Jiao J, Wu X. PMID: 42594736 [PubMed - as supplied by publisher]
	Association Between Hidradenitis Suppurativa and Polycystic Ovary Syndrome. Cutis Gill M, Babaei N, Kim D, Cervantes M, Yang S, Wu JJ. PMID: 42594401 [PubMed - indexed for MEDLINE]
	Menopausal Estrogen Therapy and Risk of Breast Cancer. Obstet Gynecol Kaunitz AM, Wright JD. PMID: 42594383 [PubMed - as supplied by publisher]
	Wait times at Christchurch Hospital for adjuvant breast irradiation and the impact of the COVID-19 pandemic. N Z Med J Robinson J, James ML, Frampton C. PMID: 42594364 [PubMed - indexed for MEDLINE]
	Formative Work to Guide Implementation of an Evidence-Based Breast and Cervical Cancer Prevention and Early Detection Behavioral Health Program in Clinics: Qualitative Study Guided by the Consolidated Framework for Implementation Research. JMIR Form Res Allicock MA, Costa C, McKenzie AH, Loomba P, Chenier RS, Shegog R, Alaniz A, Fernandez ME, Savas LS. PMID: 42594355 [PubMed - indexed for MEDLINE]
	Text Messaging as a Tool to Address Language Barriers in Cervical Cancer Screening Among Spanish-Preferred Populations: A Quality Improvement Study. Cancer Control Strelow BA, Byom E, Wangen H, Backlund J, Van Erp F, Wilson L, Herrera C, Olson R, Fought AJ, Shelden M, O'Laughlin D. PMID: 42594335 [PubMed - indexed for MEDLINE]
	Breast Neuroendocrine Carcinoma: Molecular Insights Beyond Histology. JCO Precis Oncol Schwartz CJ, Mack T, Travis W, Zhang H, Abuhadra N, Kiernan R, Montagna G, Brogi E, Pareja F, Wen HY, Ross DS. PMID: 42594324 [PubMed - indexed for MEDLINE]
	Long-Term Engagement With a Physical Activity App Among Gynecologic Cancer Survivors in the LETSGO Trial: 12-Month Prospective, Multicenter, Quasi-Experimental Study. JMIR Mhealth Uhealth Fosstveit SH, Vistad I, Skorstad M, Berntsen S. PMID: 42594257 [PubMed - indexed for MEDLINE]
	Scalp cooling versus standard cold-cap in preventing chemotherapy-induced alopecia in patients with localized breast cancer: ICELAND protocol, a randomized controlled trial and economic evaluation. PLoS One Gernier F, Lequesne J, Grellard JM, Fernette M, Gigan L, Morel A, Estienne A, Castel H, Lahaye F, Leroux T, Charles RM, Dupont C, Zarca K, Dereumaux N, Rouanet AC, Durand-Zaleski I, Clarisse B. PMID: 42594101 [PubMed - indexed for MEDLINE]
	Clinicopathological and Prognostic Implications of Circulating MicroRNA-429 in Breast Cancer Patients. Ann Afr Med Sharma S, Suryavanshi T, Agarwal P, Singh A, Gupta S, Singh AK, Singh K, Solanki V, Bhalla S. PMID: 42594098 [PubMed - as supplied by publisher]
	Selection of Breast Biopsy Markers: Effect on Breast Imaging Procedures, Follow-up, and Costs. Radiographics Moseley TW, Adrada BE, Arribas EM, Urban MW, Hesley G, Whitman GJ, Rauch RA, Guirguis MS, Kapoor MM, Lee CU. PMID: 42594023 [PubMed - indexed for MEDLINE]
	Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer. JAMA Oncol Cunningham N, Cutts RJ, Swift C, Coakley M, Sritharan P, Dunne K, Dewan M, Kilburn L, Goddard K, Hall P, Harper-Wynne C, Macpherson IR, Okines A, Wardley A, Waters S, Palmieri C, Winter M, Bliss J, Garcia-Murillas I, Turner NC. PMID: 42593771 [PubMed - as supplied by publisher]
	Validation of a novel prognostic staging system for breast cancer incorporating age at diagnosis. Breast Cancer Res Treat Johnson HM, Dong W, Shen Y, Irish W, Wong JH, Vohra NA, Tamirisa N. PMID: 42593695 [PubMed - indexed for MEDLINE]
	Factors associated with discordance between pathological and radiological tumor size and risk of re-excision in breast-conserving surgery: a post-hoc analysis within a randomized trial. Breast Cancer Res Treat Kollatos C, Pantiora E, Jazrawi A, Wärnberg F, Eriksson S, Karakatsanis A. PMID: 42593693 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 333669

Page 1 of 16684



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy